$VRSN
VeriSign, Inc

2024 Q1 Form 10-K Financial Statement

#000101447324000006 Filed on February 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $384.3M $380.4M $1.493B
YoY Change 5.46% 3.03% 4.79%
Cost Of Revenue $49.10M $48.50M $197.3M
YoY Change -1.6% -3.96% -1.69%
Gross Profit $335.2M $331.9M $1.296B
YoY Change 6.58% 4.14% 5.85%
Gross Profit Margin 87.22% 87.25% 86.79%
Selling, General & Admin $51.50M $52.70M $204.2M
YoY Change 5.1% 1.93% 4.5%
% of Gross Profit 15.36% 15.88% 15.76%
Research & Development $24.80M $22.90M $91.00M
YoY Change 2.48% 6.51% 6.18%
% of Gross Profit 7.4% 6.9% 7.02%
Depreciation & Amortization $9.800M $10.40M $44.10M
YoY Change -15.52% -11.11% -5.97%
% of Gross Profit 2.92% 3.13% 3.4%
Operating Expenses $76.30M $75.60M $295.2M
YoY Change 4.23% 3.28% 5.02%
Operating Profit $258.9M $256.3M $1.001B
YoY Change 7.29% 4.4% 6.1%
Interest Expense -$18.80M -$18.80M -$75.30M
YoY Change -200.0% 0.0% -200.0%
% of Operating Profit -7.26% -7.34% -7.53%
Other Income/Expense, Net $13.90M $14.10M $51.20M
YoY Change 23.01% 151.79% 312.9%
Pretax Income $254.0M $251.6M $976.5M
YoY Change 8.64% 8.31% 10.94%
Income Tax $59.90M -$13.10M $158.9M
% Of Pretax Income 23.58% -5.21% 16.27%
Net Earnings $194.1M $264.7M $817.6M
YoY Change 8.62% 47.47% 21.34%
Net Earnings / Revenue 50.51% 69.58% 54.76%
Basic Earnings Per Share
Diluted Earnings Per Share $1.92 $2.60 $7.90
COMMON SHARES
Basic Shares Outstanding 100.9M shares 102.1M shares 103.4M shares
Diluted Shares Outstanding 100.9M shares 103.5M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $924.7M $926.4M $926.4M
YoY Change -8.9% -5.51% -5.51%
Cash & Equivalents $731.8M $240.1M $240.1M
Short-Term Investments $192.9M $686.3M $686.3M
Other Short-Term Assets $55.70M $61.90M $61.90M
YoY Change -4.13% 4321.43% 23.31%
Inventory
Prepaid Expenses $23.30M
Receivables $6.500M $6.300M $6.300M
Other Receivables $1.400M $7.300M $7.300M
Total Short-Term Assets $988.3M $988.3M $988.3M
YoY Change -7.9% -4.85% -4.85%
LONG-TERM ASSETS
Property, Plant & Equipment $234.6M $233.2M $233.2M
YoY Change 4.31% 0.52% -2.51%
Goodwill $52.50M $52.50M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $452.4M $475.0M $475.0M
YoY Change 1465.4% 1452.29% 17.87%
Total Long-Term Assets $739.5M $760.7M $760.7M
YoY Change 8.13% 9.5% 9.5%
TOTAL ASSETS
Total Short-Term Assets $988.3M $988.3M $988.3M
Total Long-Term Assets $739.5M $760.7M $760.7M
Total Assets $1.728B $1.749B $1.749B
YoY Change -1.66% 0.9% 0.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.400M $257.4M $257.4M
YoY Change 42.42% 2526.53% 2526.53%
Accrued Expenses $83.70M $101.0M $101.0M
YoY Change 0.12% 0.8% 0.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.214B $1.189B $1.189B
YoY Change 3.63% 6.41% 6.41%
LONG-TERM LIABILITIES
Long-Term Debt $1.791B $1.790B $1.790B
YoY Change 0.12% 0.13% 0.13%
Other Long-Term Liabilities $358.9M $351.3M $351.3M
YoY Change 477.01% 465.7% -10.11%
Total Long-Term Liabilities $2.150B $2.142B $2.142B
YoY Change -1.37% -1.71% -1.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.214B $1.189B $1.189B
Total Long-Term Liabilities $2.150B $2.142B $2.142B
Total Liabilities $3.364B $3.330B $3.330B
YoY Change 0.38% 1.04% 1.04%
SHAREHOLDERS EQUITY
Retained Earnings -$13.19B -$13.39B
YoY Change -5.94% -5.76%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $13.92B
YoY Change 7.24%
Treasury Stock Shares
Shareholders Equity -$1.636B -$1.581B -$1.581B
YoY Change
Total Liabilities & Shareholders Equity $1.728B $1.749B $1.749B
YoY Change -1.66% 0.9% 0.9%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $194.1M $264.7M $817.6M
YoY Change 8.62% 47.47% 21.34%
Depreciation, Depletion And Amortization $9.800M $10.40M $44.10M
YoY Change -15.52% -11.11% -5.97%
Cash From Operating Activities $257.3M $204.2M $853.8M
YoY Change -0.66% -5.86% 2.73%
INVESTING ACTIVITIES
Capital Expenditures $3.800M $5.000M $45.80M
YoY Change -33.33% -35.06% 67.15%
Acquisitions
YoY Change
Other Investing Activities $500.2M $109.1M -$51.60M
YoY Change 20.39% -159.75% -113.47%
Cash From Investing Activities $496.4M $104.1M -$97.40M
YoY Change 21.13% -154.7% -127.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$889.1M
YoY Change -184.83%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -261.6M -226.3M -889.8M
YoY Change 17.57% 5.7% -14.1%
NET CHANGE
Cash From Operating Activities 257.3M 204.2M 853.8M
Cash From Investing Activities 496.4M 104.1M -97.40M
Cash From Financing Activities -261.6M -226.3M -889.8M
Net Change In Cash 492.1M 82.00M -133.4M
YoY Change 10.31% -143.73% -188.81%
FREE CASH FLOW
Cash From Operating Activities $257.3M $204.2M $853.8M
Capital Expenditures $3.800M $5.000M $45.80M
Free Cash Flow $253.5M $199.2M $808.0M
YoY Change 0.08% -4.78% 0.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Registrant Name
EntityRegistrantName
VERISIGN INC/CA
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001014473
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#NonoperatingGainsLosses
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 rate
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 rate
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
15900000000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100900000 shares
vrsn Additionalsharerepurchaseamountauthorized
Additionalsharerepurchaseamountauthorized
1140000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
356100000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240100000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
373600000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
686300000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
606800000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
61900000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
58300000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
988300000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1038700000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233200000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
232000000.0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
52500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
52500000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
301000000.0 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
234600000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000.0 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000.0 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000000.0 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30600000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
760700000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
694700000 usd
CY2023Q4 us-gaap Assets
Assets
1749000000 usd
CY2022Q4 us-gaap Assets
Assets
1733400000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
257400000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
226500000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
931100000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
890400000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1188500000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1116900000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
315000000.0 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
328700000 usd
CY2023Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1790200000 usd
CY2022Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
1787900000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36300000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62100000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2141500000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2178700000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
3330000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3295600000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000.0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
354900000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
354500000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101300000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
105300000 shares
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
11808000000 usd
CY2022Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
12644500000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13386400000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14204000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2600000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2700000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1581000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1562200000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1749000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1733400000 usd
CY2023 us-gaap Revenues
Revenues
1493100000 usd
CY2022 us-gaap Revenues
Revenues
1424900000 usd
CY2021 us-gaap Revenues
Revenues
1327600000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
197300000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
200700000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
191900000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91000000.0 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
85700000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
80500000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
204200000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
195400000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
188400000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
492500000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
481800000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
460800000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
1000600000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
943100000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
866800000 usd
CY2022 us-gaap Interest Expense
InterestExpense
75300000 usd
CY2021 us-gaap Interest Expense
InterestExpense
83300000 usd
CY2021 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-1300000 usd
CY2023 us-gaap Profit Loss
ProfitLoss
817600000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
673800000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
784800000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
100000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
100000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
817700000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
673900000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
784800000 usd
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
7.91
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
6.24
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
7.01
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
7.90
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
6.24
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
7.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103400000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107900000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000.0 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103500000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112200000 shares
CY2023 vrsn Excise Tax On Repurchase Of Common Stock
ExciseTaxOnRepurchaseOfCommonStock
8200000 usd
CY2022 vrsn Excise Tax On Repurchase Of Common Stock
ExciseTaxOnRepurchaseOfCommonStock
0 usd
CY2021 vrsn Excise Tax On Repurchase Of Common Stock
ExciseTaxOnRepurchaseOfCommonStock
0 usd
CY2023 us-gaap Profit Loss
ProfitLoss
817600000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
673800000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
784800000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44100000 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46900000 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
47900000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
59700000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
58600000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
53400000 usd
CY2023 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
27800000 usd
CY2022 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
7700000 usd
CY2021 us-gaap Investment Income Amortization Of Discount
InvestmentIncomeAmortizationOfDiscount
400000 usd
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3300000 usd
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3800000 usd
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6400000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1500000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9500000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000000.0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2200000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13300000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1400000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
27000000.0 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
65700000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
90500000 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
66400000 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
6200000 usd
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
162800000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
853800000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
831100000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
807200000 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1278900000 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1721500000 usd
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2654500000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1330500000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1338400000 usd
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
2870700000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45800000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27400000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000000.0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97400000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
355700000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-269200000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
901400000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1048100000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
722600000 usd
CY2023 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12300000 usd
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12300000 usd
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
12400000 usd
CY2023 us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
0 usd
CY2022 us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
0 usd
CY2021 us-gaap Repayments Of Debt Maturing In More Than Three Months
RepaymentsOfDebtMaturingInMoreThanThreeMonths
750000000.0 usd
CY2023 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
0 usd
CY2021 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
741100000 usd
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-700000 usd
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-889800000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1035800000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-719100000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-100000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-800000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-700000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-133500000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150200000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-181800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
379000000.0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228800000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
410600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
379000000.0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228800000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
72800000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
72800000 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
85600000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
239700000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
211700000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
178400000 usd
CY2023 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
7200000 usd
CY2022 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
10600000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
14700000 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9800000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
215700000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
25600000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
27000000.0 usd
CY2023Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
1000000.0 usd
CY2022Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
4100000 usd
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
160300000 usd
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
178600000 usd
CY2023Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
744900000 usd
CY2022Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
776100000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
931800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
985800000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240100000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
373600000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5400000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5400000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
379000000.0 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
686300000 usd
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
606800000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
931800000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
985800000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1690000000 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1650000000 usd
CY2023Q4 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
23800000 usd
CY2022Q4 vrsn Prepaidregistryfeescurrent
Prepaidregistryfeescurrent
24300000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23300000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24500000 usd
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
7300000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1900000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6300000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6200000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1200000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1400000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
61900000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58300000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
409000000.0 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
402700000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
261300000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
257500000 usd
CY2023Q4 us-gaap Land
Land
37900000 usd
CY2022Q4 us-gaap Land
Land
31100000 usd
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
11000000.0 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10400000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
16100000 usd
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3600000 usd
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1600000 usd
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1500000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
736900000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
706800000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
503700000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
474800000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
233200000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
232000000.0 usd
CY2023Q4 vrsn Reston Building Purchase Price
RestonBuildingPurchasePrice
19800000 usd
CY2023Q4 vrsn Reston Building Purchase Price Allocation Buildings
RestonBuildingPurchasePriceAllocationBuildings
13000000 usd
CY2023Q4 vrsn Reston Building Purchase Price Allocation Land
RestonBuildingPurchasePriceAllocationLand
6800000 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1537800000 usd
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
1537800000 usd
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1485300000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1485300000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
52500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
52500000 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
145000000 usd
CY2023Q4 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
8300000 usd
CY2022Q4 vrsn Prepaidregistryfeesnoncurent
Prepaidregistryfeesnoncurent
9100000 usd
CY2023Q4 vrsn Operating Lease Rou Asset
OperatingLeaseROUAsset
7400000 usd
CY2022Q4 vrsn Operating Lease Rou Asset
OperatingLeaseROUAsset
7200000 usd
CY2023Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
5400000 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
5400000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
4800000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
6600000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
3100000 usd
CY2022Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
2300000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
29000000.0 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30600000 usd
CY2023 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
39500000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
12500000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9800000 usd
CY2023Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
77200000 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
72000000.0 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
61200000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
59000000.0 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
49500000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
37400000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19500000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
19500000 usd
CY2023Q4 vrsn Accruedfees
Accruedfees
12300000 usd
CY2022Q4 vrsn Accruedfees
Accruedfees
12700000 usd
CY2023Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
10700000 usd
CY2022Q4 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
100000 usd
CY2023Q4 vrsn Customerincentivespayable
Customerincentivespayable
6500000 usd
CY2022Q4 vrsn Customerincentivespayable
Customerincentivespayable
7100000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5100000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5500000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2900000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3400000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
257400000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
226500000 usd
CY2023 us-gaap Revenues
Revenues
1493100000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
34100000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
60500000 usd
CY2023Q4 vrsn Long Term Operating Lease Liabilities
LongTermOperatingLeaseLiabilities
2200000 usd
CY2022Q4 vrsn Long Term Operating Lease Liabilities
LongTermOperatingLeaseLiabilities
1600000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36300000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
62100000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1800000000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1800000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-9800000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-12100000 usd
CY2023Q4 us-gaap Senior Notes
SeniorNotes
1790200000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1787900000 usd
CY2023Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
200000000.0 usd
CY2023 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2028-12-06
CY2023 vrsn Aggregate Increase Of Commitment Amount Available
AggregateIncreaseOfCommitmentAmountAvailable
150000000.0 usd
vrsn Additionalsharerepurchaseamountauthorized
Additionalsharerepurchaseamountauthorized
1140000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
356100000 usd
CY2023 vrsn Treasury Stock Shares Repurchased
TreasuryStockSharesRepurchased
4200000 shares
CY2023 vrsn Treasury Stock Shares Repurchased Average Cost Per Share
TreasuryStockSharesRepurchasedAverageCostPerShare
210.28
CY2022 vrsn Treasury Stock Shares Repurchased
TreasuryStockSharesRepurchased
5500000 shares
CY2022 vrsn Treasury Stock Shares Repurchased Average Cost Per Share
TreasuryStockSharesRepurchasedAverageCostPerShare
187.07
CY2021 vrsn Treasury Stock Shares Repurchased
TreasuryStockSharesRepurchased
3300000 shares
CY2021 vrsn Treasury Stock Shares Repurchased Average Cost Per Share
TreasuryStockSharesRepurchasedAverageCostPerShare
215.16
CY2023 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOther
100000 shares
CY2023 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other Average Cost Per Share
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOtherAverageCostPerShare
211.29
CY2022 us-gaap Revenues
Revenues
1424900000 usd
CY2021 us-gaap Revenues
Revenues
1327600000 usd
CY2023 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
857100000 usd
CY2023 vrsn Share Based Compensation Arrangement By Share Based Payment Award Employer Contribution As Percentage Of Employees Annual Salary
ShareBasedCompensationArrangementByShareBasedPaymentAwardEmployerContributionAsPercentageOfEmployeesAnnualSalary
0.08 rate
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5800000 usd
CY2022 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOther
100000 shares
CY2022 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other Average Cost Per Share
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOtherAverageCostPerShare
202.21
CY2021 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOther
100000 shares
CY2021 vrsn Treasury Stock Shares Repurchased For Tax Withholdings And Other Average Cost Per Share
TreasuryStockSharesRepurchasedForTaxWithholdingsAndOtherAverageCostPerShare
209.40
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4300000 shares
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
210.30
CY2022 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
5600000 shares
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
187.28
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3400000 shares
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
214.97
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
901400000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1048100000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
722600000 usd
CY2023Q4 vrsn Stockrepurchasedsinceinception
Stockrepurchasedsinceinception
253600000 shares
CY2023Q4 vrsn Paymentsforrepurchaseofcommonstocksinceinception
Paymentsforrepurchaseofcommonstocksinceinception
13650000000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
103400000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107900000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112000000.0 shares
CY2023 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
100000 shares
CY2022 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
100000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
200000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
103500000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108000000.0 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112200000 shares
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5500000 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
5200000 usd
CY2023 vrsn Purchase Price Of Common Stock As Percentage Of Lower Of Fair Market Value Of Common Stock Share On First Day Of Offering Period Or Last Day Of Purchase Period
PurchasePriceOfCommonStockAsPercentageOfLowerOfFairMarketValueOfCommonStockShareOnFirstDayOfOfferingPeriodOrLastDayOfPurchasePeriod
0.85 rate
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2800000 shares
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
59700000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
58600000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
53400000 usd
CY2023 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1100000 usd
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1600000 usd
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1700000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
60800000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
60200000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
55100000 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
60800000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
60200000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
55100000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
600000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
206.32
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
400000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
212.80
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
300000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
205.66
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
700000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
209.80
CY2023 vrsn Common Stock Closing Price
CommonStockClosingPrice
205.96
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
210.94
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
200.64
CY2023 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
46100000 usd
CY2022 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
14900000 usd
CY2021 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
600000 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2100000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5100000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2500000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
200000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
51200000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12400000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1300000 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2100000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
607100000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
558500000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
489400000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
369400000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
321700000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
292800000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
976500000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
880200000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
782200000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
159100000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
145100000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
97500000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
28000000.0 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
41700000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
32200000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
24400000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
26300000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
29800000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
211500000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
213100000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
159500000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-25600000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-18000000.0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3900000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
11200000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4800000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-200000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-38200000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
16100000 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-165800000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52600000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6700000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-162100000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158900000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
206400000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2600000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 rate
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
205100000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
184800000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
164300000 usd
CY2023 vrsn Deferred Tax Asset Related To Non Us Intellectual Property
DeferredTaxAssetRelatedToNonUSIntellectualProperty
118000000.0 usd
CY2022 vrsn Deferred Tax Asset Related To Non Us Intellectual Property
DeferredTaxAssetRelatedToNonUSIntellectualProperty
0 usd
CY2021 vrsn Deferred Tax Asset Related To Non Us Intellectual Property
DeferredTaxAssetRelatedToNonUSIntellectualProperty
165500000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
66100000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
100000 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
100000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
28500000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
29200000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
25500000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-15500000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-9500000 usd
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-23300000 usd
CY2023 vrsn Effectivetaxratereconciliationaccrualforuncertaintaxpositions
Effectivetaxratereconciliationaccrualforuncertaintaxpositions
-8300000 usd
CY2022 vrsn Effectivetaxratereconciliationaccrualforuncertaintaxpositions
Effectivetaxratereconciliationaccrualforuncertaintaxpositions
-1500000 usd
CY2021 vrsn Effectivetaxratereconciliationaccrualforuncertaintaxpositions
Effectivetaxratereconciliationaccrualforuncertaintaxpositions
-5100000 usd
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1000000.0 usd
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
3300000 usd
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1400000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158900000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
206400000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2600000 usd
CY2023Q4 vrsn Fair Value Of Intellectual Property
FairValueOfIntellectualProperty
1800000000 usd
CY2023 vrsn Deferred Tax Asset Related To Non Us Intellectual Property
DeferredTaxAssetRelatedToNonUSIntellectualProperty
118000000 usd
CY2021Q4 vrsn Fair Value Of Intellectual Property
FairValueOfIntellectualProperty
1200000000 usd
CY2021 vrsn Deferred Tax Asset Related To Non Us Intellectual Property
DeferredTaxAssetRelatedToNonUSIntellectualProperty
165500000 usd
CY2023Q4 vrsn Deferred Tax Asset Valuation Allowance Change In Tax Systems
DeferredTaxAssetValuationAllowanceChangeInTaxSystems
64700000 usd
CY2023Q4 vrsn Deferred Tax Asset Intellectual Property
DeferredTaxAssetIntellectualProperty
266200000 usd
CY2022Q4 vrsn Deferred Tax Asset Intellectual Property
DeferredTaxAssetIntellectualProperty
147000000.0 usd
CY2023Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
72900000 usd
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
73700000 usd
CY2023Q4 vrsn Deferred Tax Asset Research And Development Costs
DeferredTaxAssetResearchAndDevelopmentCosts
23600000 usd
CY2022Q4 vrsn Deferred Tax Asset Research And Development Costs
DeferredTaxAssetResearchAndDevelopmentCosts
12000000.0 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
4600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3800000 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2200000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3400000 usd
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6000000.0 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1800000 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
375500000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
241700000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
73600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5500000 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
301900000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
236200000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
900000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1600000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
301000000.0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
234600000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15100000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
16000000.0 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
100000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
100000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5000000.0 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1400000 usd
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
10600000 usd
CY2022 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2400000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
9600000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
15100000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
7100000 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due With In One Year
PurchaseObligationsAndContractualAgreementsDueWithInOneYear
141300000 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due In Second Year
PurchaseObligationsAndContractualAgreementsDueInSecondYear
602500000 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due In Third Year
PurchaseObligationsAndContractualAgreementsDueInThirdYear
48000000.0 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due In Fourth Year
PurchaseObligationsAndContractualAgreementsDueInFourthYear
596500000 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due In Fifth Year
PurchaseObligationsAndContractualAgreementsDueInFifthYear
20500000 usd
CY2023Q4 vrsn Purchase Obligations And Contractual Agreements Due After Fifth Year
PurchaseObligationsAndContractualAgreementsDueAfterFifthYear
800700000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
2209500000 usd
CY2023Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
7100000 usd
CY2023 vrsn Expiration Dateof Registry Agreement
ExpirationDateofRegistryAgreement
2024-11-30
CY2023 vrsn Registry Fee Per Transaction
RegistryFeePerTransaction
0.25 usd
CY2023 us-gaap Payments For Fees
PaymentsForFees
38100000 usd
CY2022 us-gaap Payments For Fees
PaymentsForFees
39900000 usd
CY2021 us-gaap Payments For Fees
PaymentsForFees
40600000 usd
CY2023Q4 vrsn Icannssr Payments
ICANNSSRPayments
4000000.0 usd
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Name
AuditorName
KPMG LLP
CY2023 dei Auditor Location
AuditorLocation
McLean, VA
CY2023 dei Auditor Firm
AuditorFirmId
185

Files In Submission

Name View Source Status
0001014473-24-000006-index-headers.html Edgar Link pending
0001014473-24-000006-index.html Edgar Link pending
0001014473-24-000006.txt Edgar Link pending
0001014473-24-000006-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrsn-20231231.htm Edgar Link pending
vrsn-20231231.xsd Edgar Link pending
vrsn-20231231x10kxex1010.htm Edgar Link pending
vrsn-20231231x10kxex2101.htm Edgar Link pending
vrsn-20231231x10kxex2301.htm Edgar Link pending
vrsn-20231231x10kxex3101.htm Edgar Link pending
vrsn-20231231x10kxex3102.htm Edgar Link pending
vrsn-20231231x10kxex3201.htm Edgar Link pending
vrsn-20231231x10kxex3202.htm Edgar Link pending
vrsn-20231231x10kxex97.htm Edgar Link pending
vrsn-20231231_g1.jpg Edgar Link pending
vrsn-20231231_cal.xml Edgar Link unprocessable
vrsn-20231231_def.xml Edgar Link unprocessable
vrsn-20231231_lab.xml Edgar Link unprocessable
vrsn-20231231_pre.xml Edgar Link unprocessable
vrsn-20231231_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable